In this episode of the podcast, Joe interviews D.C.-based attorney and Executive Director of the Association of Entheogenic Practitioners, Danny Peterson. They discuss psychedelics, religion, and freedom in the United States.
www.psychedelicstoday.com
In this episode of the podcast, Joe interviews 2 hosts of fellow long-running psychedelics podcast, Entheogen: Joe Zap and Kevin W. They discuss the early days of cannabis, Timothy Leary, gurus, conspiracies, and more.
www.psychedelicstoday.com
In this week's Solidarity Fridays episode, Joe and Kyle discuss Colorado possibly legalizing several drugs through the Natural Medicine Healing Act, and CO also establishing guidelines around EMTs and ketamine administration.
www.psychedelicstoday.com
In this episode of the podcast, Joe interviews Ayize Jama-Everett, Courtney Watson, Leticia Brown, and Kufikiri Imara of A Table of Our Own: a for-Black-people by-Black-people psychedelic conference and documentary.
www.psychedelicstoday.com
In this week's Solidarity Fridays episode, Joe and Kyle dive into all things microdosing: Why people are doing it, possible negative effects, how it could work with pain, and more. And they discuss good outcomes in therapy.
www.psychedelicstoday.com
In this episode of the podcast, Kyle interviews Ryan Zurrer, Founder and Managing Director of Vine Ventures, a psychedelic-focused venture fund which just announced an SPV with MAPS called the Regenerative Financing Vine.
www.psychedelicstoday.com
In this week's Solidarity Fridays episode, David interviews Co-founder and CMO of Awakn Life Sciences, Dr. Ben Sessa, and then David and Kyle interview Director, CEO, and Chairman of Mydecine Innovations Group, Josh Bartch.
www.psychedelicstoday.com
In this episode, Joe interviews 17-year veteran of federal policy and founder of Healing Equity and Liberation (HEAL) Organization, Micah Haskell-Hoehl. He discusses HEAL's goals and his path to federal policy and psychedelics.
www.psychedelicstoday.com
In this week's Solidarity Fridays episode, Joe and Kyle address some tweets and discuss ketamine and mysticism, then Joe interviews CEO of MINDCURE, Kelsey Ramsden, about MINDCURE's 2 main pieces: iSTRYM and the Desire Project.
www.psychedelicstoday.com